These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 25738895)

  • 1. Energy metabolism in a matched model of radiation resistance for head and neck squamous cell cancer.
    Mims J; Bansal N; Bharadwaj MS; Chen X; Molina AJ; Tsang AW; Furdui CM
    Radiat Res; 2015 Mar; 183(3):291-304. PubMed ID: 25738895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of DNA methylation and gene expression in radiation-resistant head and neck tumors.
    Chen X; Liu L; Mims J; Punska EC; Williams KE; Zhao W; Arcaro KF; Tsang AW; Zhou X; Furdui CM
    Epigenetics; 2015; 10(6):545-61. PubMed ID: 25961636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Broad phenotypic changes associated with gain of radiation resistance in head and neck squamous cell cancer.
    Bansal N; Mims J; Kuremsky JG; Olex AL; Zhao W; Yin L; Wani R; Qian J; Center B; Marrs GS; Porosnicu M; Fetrow JS; Tsang AW; Furdui CM
    Antioxid Redox Signal; 2014 Jul; 21(2):221-36. PubMed ID: 24597745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased radiation sensitivity of head and neck squamous cell carcinoma with sphingosine kinase 1 inhibition.
    Sinha UK; Schorn VJ; Hochstim C; Chinn SB; Zhu S; Masood R
    Head Neck; 2011 Feb; 33(2):178-88. PubMed ID: 20848438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucose, not glutamine, is the dominant energy source required for proliferation and survival of head and neck squamous carcinoma cells.
    Sandulache VC; Ow TJ; Pickering CR; Frederick MJ; Zhou G; Fokt I; Davis-Malesevich M; Priebe W; Myers JN
    Cancer; 2011 Jul; 117(13):2926-38. PubMed ID: 21692052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leptin regulates energy metabolism in MCF-7 breast cancer cells.
    Blanquer-Rosselló MDM; Oliver J; Sastre-Serra J; Valle A; Roca P
    Int J Biochem Cell Biol; 2016 Mar; 72():18-26. PubMed ID: 26772821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbonyl reductase 1 is a new target to improve the effect of radiotherapy on head and neck squamous cell carcinoma.
    Yun M; Choi AJ; Lee YC; Kong M; Sung JY; Kim SS; Eun YG
    J Exp Clin Cancer Res; 2018 Oct; 37(1):264. PubMed ID: 30376862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioresistant head and neck squamous cell carcinoma cells: intracellular signaling, putative biomarkers for tumor recurrences and possible therapeutic targets.
    Skvortsov S; Jimenez CR; Knol JC; Eichberger P; Schiestl B; Debbage P; Skvortsova I; Lukas P
    Radiother Oncol; 2011 Oct; 101(1):177-82. PubMed ID: 21700351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulation of the toll-like receptor 3 promotes metabolic reprogramming in head and neck carcinoma cells.
    Veyrat M; Durand S; Classe M; Glavan TM; Oker N; Kapetanakis NI; Jiang X; Gelin A; Herman P; Casiraghi O; Zagzag D; Enot D; Busson P; Vérillaud B
    Oncotarget; 2016 Dec; 7(50):82580-82593. PubMed ID: 27791989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic phenotype of bladder cancer.
    Massari F; Ciccarese C; Santoni M; Iacovelli R; Mazzucchelli R; Piva F; Scarpelli M; Berardi R; Tortora G; Lopez-Beltran A; Cheng L; Montironi R
    Cancer Treat Rev; 2016 Apr; 45():46-57. PubMed ID: 26975021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lactate as a predictive marker for tumor recurrence in patients with head and neck squamous cell carcinoma (HNSCC) post radiation: a prospective study over 15 years.
    Blatt S; Voelxen N; Sagheb K; Pabst AM; Walenta S; Schroeder T; Mueller-Klieser W; Ziebart T
    Clin Oral Investig; 2016 Nov; 20(8):2097-2104. PubMed ID: 26728026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ACR appropriateness criteria retreatment of recurrent head and neck cancer after prior definitive radiation expert panel on radiation oncology-head and neck cancer.
    McDonald MW; Lawson J; Garg MK; Quon H; Ridge JA; Saba N; Salama JK; Smith RV; Yeung AR; Yom SS; Beitler JJ;
    Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1292-8. PubMed ID: 21530100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial dysfunction is responsible for fatty acid synthase inhibition-induced apoptosis in breast cancer cells by PdpaMn.
    Wang Q; Du X; Zhou B; Li J; Lu W; Chen Q; Gao J
    Biomed Pharmacother; 2017 Dec; 96():396-403. PubMed ID: 29031197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging tumor perfusion and oxidative metabolism in patients with head-and-neck cancer using 1- [11C]-acetate PET during radiotherapy: preliminary results.
    Sun A; Johansson S; Turesson I; Daşu A; Sörensen J
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):554-60. PubMed ID: 21236601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatty acid synthase as a potential therapeutic target in feline oral squamous cell carcinoma.
    Walz JZ; Saha J; Arora A; Khammanivong A; O'Sullivan MG; Dickerson EB
    Vet Comp Oncol; 2018 Mar; 16(1):E99-E108. PubMed ID: 28871635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukemia cells demonstrate a different metabolic perturbation provoked by 2-deoxyglucose.
    Miwa H; Shikami M; Goto M; Mizuno S; Takahashi M; Tsunekawa-Imai N; Ishikawa T; Mizutani M; Horio T; Gotou M; Yamamoto H; Wakabayashi M; Watarai M; Hanamura I; Imamura A; Mihara H; Nitta M
    Oncol Rep; 2013 May; 29(5):2053-7. PubMed ID: 23440281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondria: The ketogenic diet--A metabolism-based therapy.
    Vidali S; Aminzadeh S; Lambert B; Rutherford T; Sperl W; Kofler B; Feichtinger RG
    Int J Biochem Cell Biol; 2015 Jun; 63():55-9. PubMed ID: 25666556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High glucose uptake unexpectedly is accompanied by high levels of the mitochondrial ß-F1-ATPase subunit in head and neck squamous cell carcinoma.
    Huebbers CU; Adam AC; Preuss SF; Schiffer T; Schilder S; Guntinas-Lichius O; Schmidt M; Klussmann JP; Wiesner RJ
    Oncotarget; 2015 Nov; 6(34):36172-84. PubMed ID: 26452026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different mechanisms of cell death in radiosensitive and radioresistant p53 mutated head and neck squamous cell carcinoma cell lines exposed to carbon ions and x-rays.
    Maalouf M; Alphonse G; Colliaux A; Beuve M; Trajkovic-Bodennec S; Battiston-Montagne P; Testard I; Chapet O; Bajard M; Taucher-Scholz G; Fournier C; Rodriguez-Lafrasse C
    Int J Radiat Oncol Biol Phys; 2009 May; 74(1):200-9. PubMed ID: 19362238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2-Deoxy-d-glucose Suppresses the In Vivo Antitumor Efficacy of Erlotinib in Head and Neck Squamous Cell Carcinoma Cells.
    Sobhakumari A; Orcutt KP; Love-Homan L; Kowalski CE; Parsons AD; Knudson CM; Simons AL
    Oncol Res; 2016; 24(1):55-64. PubMed ID: 27178822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.